{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:53Z","timestamp":1786119293033,"version":"build-2736575974"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/mol.0b013e32832aee68","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T07:17:23Z","timestamp":1242890243000},"page":"227-235","source":"Crossref","is-referenced-by-count":37,"title":["Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues"],"prefix":"10.1097","volume":"20","author":[{"given":"Roland","family":"Stocker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"R2-13-20210205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1179\/135100008X259196","article-title":"Antiatherosclerotic and antidiabetic properties of probucol and related compounds","volume":"13","author":"Tanous","year":"2008","journal-title":"Redox Rep"},{"key":"R3-13-20210205","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0002-9149(94)90579-7","article-title":"The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)","volume":"74","author":"Walldius","year":"1994","journal-title":"Am J Cardiol"},{"key":"R4-13-20210205","first-page":"277","article-title":"The synthesis, metabolism, and biological activity of probucol and its analogs","author":"Barnhart","year":"1991"},{"key":"R5-13-20210205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.107.120931","article-title":"Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes","volume":"321","author":"Guo","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R6-13-20210205","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0960-894X(02)00516-4","article-title":"Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis","volume":"12","author":"Meng","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"R7-13-20210205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/ajcn\/23.9.1229","article-title":"Hypocholesterolemic effect of 4,4\u2032-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (Probucol)","volume":"23","author":"Barnhart","year":"1970","journal-title":"Am J Clin Nutr"},{"key":"R8-13-20210205","doi-asserted-by":"crossref","first-page":"29H","DOI":"10.1016\/0002-9149(86)90434-0","article-title":"Effects of probucol on xanthomata regression in familial hypercholesterolemia","volume":"57","author":"Yamamoto","year":"1986","journal-title":"Am J Cardiol"},{"key":"R9-13-20210205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0735-1097(01)01783-1","article-title":"Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST)","volume":"39","author":"Sawayama","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R10-13-20210205","first-page":"15","article-title":"Effect of probucol on elderly hypercholesterolemic patients in the FAST study","volume":"97","author":"Sawayama","year":"2006","journal-title":"Fukuoka Igaku Zasshi"},{"key":"R11-13-20210205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E610","article-title":"Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan","volume":"15","author":"Yamashita","year":"2008","journal-title":"J Atheroscler Thromb"},{"key":"R12-13-20210205","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N Engl J Med"},{"key":"R13-13-20210205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/jpet.106.118612","article-title":"Probucol [4,4\u2032-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] inhibits compensatory remodeling and promotes lumen loss associated with atherosclerosis in apolipoprotein E-deficient mice","volume":"321","author":"Wu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R14-13-20210205","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1073\/pnas.84.16.5928","article-title":"Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia","volume":"84","author":"Kita","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-13-20210205","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1073\/pnas.84.21.7725","article-title":"Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit","volume":"84","author":"Carew","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-13-20210205","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.1237725100","article-title":"Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI\/apolipoprotein E double knockout mouse","volume":"100","author":"Braun","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-13-20210205","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI119479","article-title":"Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice","volume":"99","author":"Zhang","year":"1997","journal-title":"J Clin Invest"},{"key":"R18-13-20210205","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/01.ATV.20.8.e26","article-title":"Site-specific antiatherogenic effect of probucol in apolipoprotein E deficient mice","volume":"20","author":"Witting","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R19-13-20210205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"R20-13-20210205","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jacc.2004.11.065","article-title":"Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies","volume":"45","author":"Moreno","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R21-13-20210205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM199708073370601","article-title":"Probucol and multivitamins in the prevention of restenosis after coronary angioplasty","volume":"337","author":"Tardif","year":"1997","journal-title":"N Engl J Med"},{"key":"R22-13-20210205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0735-1097(97)00270-2","article-title":"Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial","volume":"30","author":"Yokoi","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R23-13-20210205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9149(00)01013-4","article-title":"Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART])","volume":"86","author":"Daida","year":"2000","journal-title":"Am J Cardiol"},{"key":"R24-13-20210205","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.0000062682.40051.43","article-title":"Probucol promotes functional reendothelialization in balloon-injured rabbit aortas","volume":"107","author":"Lau","year":"2003","journal-title":"Circulation"},{"key":"R25-13-20210205","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/01.CIR.88.2.628","article-title":"Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis","volume":"88","author":"Schneider","year":"1993","journal-title":"Circulation"},{"key":"R26-13-20210205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2006.01.025","article-title":"Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization","volume":"189","author":"Tanous","year":"2006","journal-title":"Atherosclerosis"},{"key":"R27-13-20210205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9149(98)00323-3","article-title":"Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis","volume":"82","author":"Sekiya","year":"1998","journal-title":"Am J Cardiol"},{"key":"R28-13-20210205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ccd.10346","article-title":"Effect of antioxidant probucol for preventing stent restenosis","volume":"57","author":"Kim","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"R29-13-20210205","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.0000047525.58618.3C","article-title":"Effects of AGI-1067 and probucol after percutaneous coronary interventions","volume":"107","author":"Tardif","year":"2003","journal-title":"Circulation"},{"key":"R30-13-20210205","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ahj.2006.05.005","article-title":"Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study","volume":"152","author":"Nunes","year":"2006","journal-title":"Am Heart J"},{"key":"R31-13-20210205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.99.1.30","article-title":"Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group","volume":"99","author":"C\u00f4t\u00e9","year":"1999","journal-title":"Circulation"},{"key":"R32-13-20210205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10837450802244843","article-title":"Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30","volume":"13","author":"Thybo","year":"2008","journal-title":"Pharm Dev Technol"},{"key":"R33-13-20210205","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biomaterials.2008.10.005","article-title":"The preclinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts","volume":"30","author":"Steigerwald","year":"2009","journal-title":"Biomaterials"},{"key":"R34-13-20210205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1394.006","article-title":"Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough","volume":"1103","author":"Ablamunits","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R35-13-20210205","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00125-006-0210-y","article-title":"Induction of adiponectin in skeletal muscle of type 2 diabetic mice: in vivo and in vitro studies","volume":"49","author":"Delaigle","year":"2006","journal-title":"Diabetologia"},{"key":"R37-13-20210205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.diabres.2005.05.012","article-title":"Probucol delays progression of diabetic nephropathy","volume":"71","author":"Endo","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"R38-13-20210205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2006.07.053","article-title":"Combined effect of probucol and insulin on renal damage in diabetic rats fed a high cholesterol diet","volume":"548","author":"Yoshida","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R39-13-20210205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00410275","article-title":"The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague\u2013Dawley rat","volume":"38","author":"Soulis-Liparota","year":"1995","journal-title":"Diabetologia"},{"key":"R40-13-20210205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2003.08.005","article-title":"Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency","volume":"171","author":"Noto","year":"2003","journal-title":"Atherosclerosis"},{"key":"R41-13-20210205","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI13288","article-title":"Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice","volume":"108","author":"Miettinen","year":"2001","journal-title":"J Clin Invest"},{"key":"R42-13-20210205","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbalip.2007.04.015","article-title":"Probucol therapy overcomes the reproductive defect in CTP: phosphocholine cytidylyltransferase beta2 knockout mice","volume":"1771","author":"Gunter","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"R43-13-20210205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2007.12.031","article-title":"Probucol markedly reduces HDL phospholipids and elevated pre\u03b21-HDL without delayed conversion into \u03b1-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling","volume":"200","author":"Miida","year":"2008","journal-title":"Atherosclerosis"},{"key":"R44-13-20210205","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/01.ATV.19.5.1325","article-title":"Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-I-dependent mechanism","volume":"19","author":"Rinninger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R45-13-20210205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0021-9150(93)90203-7","article-title":"Probucol inhibits mononuclear cell adhesion to vascular endothelium in the cholesterol-fed rabbit","volume":"100","author":"Ferns","year":"1993","journal-title":"Atherosclerosis"},{"key":"R46-13-20210205","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.ATV.0000174125.89058.b6","article-title":"Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice","volume":"25","author":"Choy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R47-13-20210205","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.freeradbiomed.2007.08.010","article-title":"Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis","volume":"43","author":"Wu","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"R48-13-20210205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9150(02)00023-0","article-title":"Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits","volume":"163","author":"Br\u00e4sen","year":"2002","journal-title":"Atherosclerosis"},{"key":"R49-13-20210205","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1021\/jo00065a013","article-title":"A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants","volume":"58","author":"Pryor","year":"1993","journal-title":"J Org Chem"},{"key":"R50-13-20210205","doi-asserted-by":"crossref","first-page":"15612","DOI":"10.1074\/jbc.M414256200","article-title":"Probucol protects against hypochlorite-induced endothelial dysfunction. Identification of a novel pathway of probucol oxidation to a biologically active intermediate","volume":"280","author":"Witting","year":"2005","journal-title":"J Biol Chem"},{"key":"R51-13-20210205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/FJC.0b013e31809501dc","article-title":"Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis","volume":"50","author":"Van Antwerpen","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R52-13-20210205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"key":"R53-13-20210205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1172\/JCI117334","article-title":"A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits","volume":"94","author":"Fruebis","year":"1994","journal-title":"J Clin Invest"},{"key":"R54-13-20210205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI6391","article-title":"Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits","volume":"104","author":"Witting","year":"1999","journal-title":"J Clin Invest"},{"key":"R55-13-20210205","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.20052321","article-title":"Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging","volume":"203","author":"Wu","year":"2006","journal-title":"J Exp Med"},{"key":"R57-13-20210205","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1172\/JCI117953","article-title":"Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation","volume":"95","author":"Keaney","year":"1995","journal-title":"J Clin Invest"},{"key":"R58-13-20210205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1291\/hypres.27.311","article-title":"Long-term treatment with probucol improves endothelial function in patients with coronary artery disease","volume":"27","author":"Tagawa","year":"2004","journal-title":"Hypertens Res"},{"key":"R59-13-20210205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/01.fjc.0000211763.13894.87","article-title":"Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy","volume":"47","author":"Aubin","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"R60-13-20210205","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.HYP.0000242336.58387.1f","article-title":"NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells","volume":"48","author":"Jiang","year":"2006","journal-title":"Hypertension"},{"key":"R61-13-20210205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.ATV.0000148405.18071.6a","article-title":"Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction","volume":"25","author":"Kawamura","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R62-13-20210205","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.0000140262.20831.8F","article-title":"Serum myeloperoxidase levels independently predict endothelial dysfunction in humans","volume":"110","author":"Vita","year":"2004","journal-title":"Circulation"},{"key":"R63-13-20210205","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/01.ATV.0000143388.20994.fa","article-title":"Hypochlorous acid impairs EDNO bioactivity through a superoxide-dependent mechanism","volume":"24","author":"Stocker","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R64-13-20210205","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.105.598698","article-title":"Heme oxygenase-1. A novel drug target for atherosclerotic diseases?","volume":"114","author":"Stocker","year":"2006","journal-title":"Circulation"},{"key":"R65-13-20210205","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/01.CIR.0000142610.10530.25","article-title":"Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1","volume":"110","author":"Deng","year":"2004","journal-title":"Circulation"},{"key":"R66-13-20210205","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/dc07-2126","article-title":"Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"R67-13-20210205","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2008.398","article-title":"Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes","volume":"74","author":"Fukui","year":"2008","journal-title":"Kidney Int"},{"key":"R68-13-20210205","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1124\/jpet.102.048132","article-title":"AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent","volume":"305","author":"Sundell","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R69-13-20210205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2006.11.039","article-title":"Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial","volume":"197","author":"Tardif","year":"2008","journal-title":"Atherosclerosis"},{"key":"R70-13-20210205","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(08)60763-1","article-title":"Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Tardif","year":"2008","journal-title":"Lancet"},{"key":"R71-13-20210205","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.103.059733","article-title":"Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent","volume":"308","author":"Kunsch","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R72-13-20210205","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/ATVBAHA.107.143552","article-title":"A novel class of antioxidants inhibit LPS induction of tissue factor by selective inhibition of the activation of ASK1 and MAP kinases","volume":"27","author":"Luyendyk","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R73-13-20210205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2337\/diab.42.8.1179","article-title":"MDL 29311. Antioxidant with marked lipid- and glucose-lowering activity in diabetic rats and mice","volume":"42","author":"Johnson","year":"1993","journal-title":"Diabetes"},{"key":"R74-13-20210205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0026-0495(94)90251-8","article-title":"MDL 29311, an analog of probucol, decreases triglycerides in rats by increasing hepatic clearance of very-low-density lipoprotein","volume":"43","author":"Sheetz","year":"1994","journal-title":"Metabolism"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOL.0b013e32832aee68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:07Z","timestamp":1786038907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200906000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e32832aee68","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}